Article Sidebar

PDF
Date Published: 24/10/2021
Abstract Views: 319
Views PDF: 209
DOI: https://doi.org/10.51298/vmj.v506i2.1259
Issue
Vol. 506 No. 2 (2021)
Section
Các bài báo
How to Cite
Quang Nam, T. ., Truong, S. ., Khánh Chi, H. ., Hoàng Bảo, L. ., Ngô Tất Thắng, Đinh ., Viết Thắng, T. ., Văn Lượng, T. ., Tùng Phát, M. ., Phương Thảo, M. ., & Đức Minh, Đỗ . (2021). THE ASSOCIATION BETWEEN ADIPOQ rs1501299 AND TYPE 2 DIABETES IN VIETNAMESE POPULATION. Vietnam Medical Journal, 506(2). https://doi.org/10.51298/vmj.v506i2.1259

THE ASSOCIATION BETWEEN ADIPOQ rs1501299 AND TYPE 2 DIABETES IN VIETNAMESE POPULATION

Trần Quang Nam1, Steven Truong2, Hoàng Khánh Chi3, Lê Hoàng Bảo3, Đinh Ngô Tất Thắng3, Trần Viết Thắng1, Trần Văn Lượng3, Mã Tùng Phát1, Mai Phương Thảo1, Đỗ Đức Minh1,
1 University of Medicine and Pharmacy at Ho Chi Minh City
2 Department of Biological Engineering, Massachusetts Institute of Technolo
3 University Medical Center Ho Chi Minh City

Main Article Content

Abstract

Background: Genetic factor plays an important role in pathophysiology of type 2 diabetes. In this study, we evaluated the association between ADIPOQ rs1501299 and type 2 diabetes in Vietnamese population. Objectives and methods: In this cross sectional study, 376 type 2 diabetic patients and 392 controls were recruited and genotyped for ADIPOQ rs1501299 by real-time PCR. Results: ADIPOQ rs1501299 was not statistically associated with type 2 diabetes in Vietnamese population by different statistical models. The rs1501299 carriers do not increase the risk of developing type 2 diabetes. Conclusion: ADIPOQ rs1501299 is not associated with type 2 diabetes mellitus in Vietnamese population.

Article Details

Keywords

type 2 diabetes mellitus, single nucleotide polymorphism, ADIPOQ gene

References

1. Ogurtsova K, Fernandes JD da R, Huang Y, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40-50. doi:10.1016/j.diabres.2017.03.024
2. Phan HH, Lam HV, Le NT, et al. Prevalence and clinical profile of undiagnosed diabetes mellitus: data from a tertiary hospital. Endocr Metab Immune Disord Drug Targets. October 2020. doi:10.2174/1871530320666201014151408
3. Fukushima M, Usami M, Ikeda M, et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism. 2004;53(7): 831-835. doi:10.1016/j.metabol.2004.02.012
4. Duncan BB, Schmidt MI, Pankow JS, et al. Adiponectin and the Development of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study. Diabetes. 2004;53(9):2473-2478. doi:10.2337/diabetes.53.9.2473
5. Wang Y, Meng R-W, Kunutsor SK, et al. Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis. Sci Rep. 2018;8. doi:10.1038/s41598-017-18709-9
6. Ong KL, Li M, Tso AWK, et al. Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol. 2010;163(2):251-257. doi:10.1530/EJE-10-0251
7. Tsai M-K, Wang H-MD, Shiang J-C, et al. Sequence Variants of ADIPOQ and Association with Type 2 Diabetes Mellitus in Taiwan Chinese Han Population. Sci World J. 2014;2014:e650393. doi:10.1155/2014/650393
8. Cui M, Gao Y, Zhao Y, et al. Association between Adiponectin Gene Polymorphism and Environmental Risk Factors of Type 2 Diabetes Mellitus among the Chinese Population in Hohhot. BioMed Res Int. 2020;2020:e6383906. doi:10.1155/2020/6383906
9. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14-S31. doi:10.2337/dc20-S002
10. Solé X, Guinó E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinforma Oxf Engl. 2006;22(15):1928-1929. doi:10.1093/ bioinformatics/ btl268